Skip to content

AI-Driven DECIPHER-M Project Launches to Combat Cancer Metastasis

This innovative project connects diverse data types to predict metastasis risk. It could revolutionize cancer treatment and improve patient survival.

This is a collage image, there are animation of a person's face and some text for each image.
This is a collage image, there are animation of a person's face and some text for each image.

AI-Driven DECIPHER-M Project Launches to Combat Cancer Metastasis

A groundbreaking research project, DECIPHER-M, is underway to combat cancer cell spread using artificial intelligence. Led by Prof. Jakob Nikolas Kather, the project aims to enhance cancer survival rates by predicting individual metastasis risk and developing tailored treatment strategies. The collaborative effort involves institutions from Dresden, Aachen, and other cities, with a total budget of around €9 million.

The DECIPHER-M project, coordinated by Prof. Kather at the Technical University Dresden, involves a multimodal approach. It connects diverse data types, including X-rays and MRI scans, to create a comprehensive view of cancer development. The project's initial funding of approximately €5.5 million comes from the Federal Ministry of Education and Research (BMBF) for the first three years, with the total budget ideally reaching around €9 million. Partners from Aachen, Essen, Heidelberg, Mainz, and Munich are also contributing to the project, which is set to run from 2023 to 2030.

The University Hospital RWTH Aachen is among the collaborating institutions, utilizing the DECIPHER-M AI model with various data sources. The project's ultimate goal is to improve cancer patient survival rates by predicting individual metastasis risk more precisely and developing personalized treatment options.

The DECIPHER-M project, with a budget of around €9 million, is poised to revolutionize cancer treatment. By predicting individual metastasis risk and developing personalized strategies, it aims to enhance cancer survival rates. The collaborative effort, led by Prof. Kather and involving multiple institutions, is expected to yield significant advancements in cancer research and treatment.

Read also:

Latest